Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
G

Rationale and Early Results of Innate Immunity and Immune Check Point Blockade in the Treatment of MDS

By Cleveland Clinic Taussig Cancer Institute FEATURING Guillermo Garcia-Manero
By Cleveland Clinic Taussig Cancer Institute FEATURING Guillermo Garcia-Manero
109 views
December 12, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
MDS/MPN
10:06
Cleveland Clinic Taussig Cancer Institute

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment …

Feat. A. Gerds
16:58
Cleveland Clinic Taussig Cancer Institute

JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: What Are th…

Feat. A. Gerds
30:31
Cleveland Clinic Taussig Cancer Institute

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prog…

Feat. V. Santini
28:01
Cleveland Clinic Taussig Cancer Institute

The Changing Genomic Landscape of MPNs: Impact on Clinical Care

Feat. L. Michaelis
07:40
Cleveland Clinic Taussig Cancer Institute

MPN, MDS and Aplastic Anemia Case Discussions

Feat. L. Michaelis
28:08
Cleveland Clinic Taussig Cancer Institute

Rationale and Early Results of Innate Immunity and Immune Check Poin…

Feat. G. Garcia-Manero
14:50
Cleveland Clinic Taussig Cancer Institute

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies an…

Feat. A. Gerds